Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis

This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare utilization patterns, and direct costs from a healthcare system perspective. This retrospective cohort study was performed using Tuscan administrativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Convertino, Irma, Lorenzoni, Valentina, Gini, Rosa, Turchetti, Giuseppe, Fini, Elisabetta, Giometto, Sabrina, Bartolini, Claudia, Paoletti, Olga, Ferraro, Sara, Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Blandizzi, Corrado, Tuccori, Marco, Lucenteforte, Ersilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058541/
https://www.ncbi.nlm.nih.gov/pubmed/36986565
http://dx.doi.org/10.3390/ph16030465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058541/
https://www.ncbi.nlm.nih.gov/pubmed/36986565
http://dx.doi.org/10.3390/ph16030465

Ejemplares similares